Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

要約

With the rapid advancement of laparoscopic techniques, the minimally invasive benefits of laparoscopic splenectomy combined with pericardial devascularization have become increasingly evident. In this context, we present a protocol for performing laparoscopic splenectomy alongside pericardial devascularization to treat hypersplenism and esophageal variceal hemorrhage resulting from portal hypertension.

要約

Hypersplenism and esophageal variceal hemorrhage caused by portal hypertension are common and serious complications of decompensated cirrhosis. In recent years, with the widespread application of various therapeutic methods such as drugs, endoscopy, splenic artery embolization, transjugular intrahepatic portal shunt, and liver transplantation, the role of surgery in the treatment of portal hypertension has gradually diminished, and the indications for surgical treatment have become more strictly defined. However, according to the clinical practice in China, surgical treatment of portal hypertension still holds an important role that other treatments cannot fully replace. In fact, surgical treatment of portal hypertension is widely performed in hospitals at all levels in China, saving numerous lives. Splenectomy combined with pericardial devascularization (SPD) is the most common surgical method for treating hypersplenism and esophageal variceal hemorrhage caused by portal hypertension. Long-term clinical practice has proven that SPD is a safe and effective treatment for hypersplenism and esophageal variceal rupture and hemorrhage due to portal hypertension. With the rapid development of laparoscopic techniques, the minimally invasive advantages of laparoscopic splenectomy combined with pericardial devascularization (LSPD) have become increasingly evident. However, the successful performance of LSPD mainly depends on the skill and proficiency of the surgeon. In this context, this article presents detailed techniques for LSPD.

概要

China has a high number of hepatitis cases, and hepatitis patients often develop cirrhosis¹. Portal hypertension is a common complication of liver cirrhosis^2,3. The common clinical manifestations include splenomegaly, hypersplenism, peritoneal effusion, portal-systemic collateral circulation, and portal hypertensive gastroenteropathy^3,4,5. The rupture and hemorrhage of esophageal and gastric varices is the most critical complication and the leading cause of death in decompensated cirrhosis^6,7,8.

In recent years, with the widespread use of various therapeutic methods such as drugs, endoscopy, splenic artery embolization, transjugular intrahepatic portal shunt, and liver transplantation, the role of surgery in treating portal hypertension has gradually diminished, and the indications for surgical treatment have been more strictly limited^{6,9,10,11,12,13}. However, the long-standing use of surgical treatment for portal hypertension, particularly splenectomy combined with pericardial devascularization (SPD), has saved numerous lives and continues to play an indispensable role in China^14,15. Long-term surgical practice has shown that SPD is safe and effective, with a low incidence of rebleeding and hepatic encephalopathy^6,9,14,15,16.

With the popularization of minimally invasive surgery and advancements in laparoscopic techniques, laparoscopic splenectomy combined with pericardial devascularization (LSPD) has already been applied in clinical practice^{17,18,19,20,21}. However, LSPD places higher demands on the technical proficiency of the surgeon. Given this, the present article provides detailed techniques for LSPD in treating hypersplenism and esophageal variceal hemorrhage caused by portal hypertension.

プロトコル

A total of 8 patients who underwent LSPD between October 2012 and September 2022 were included in this study. The operations were approved by the institutional review board of The First Affiliated Hospital of Jinan University. All patients provided written informed consent. The consumables and equipment required for the study are listed in the Table of Materials.

1. Inclusion criteria

1. Include patients with splenomegaly (The spleen is over 12 cm in any diameter) and hypersplenism (Platelet count less than 75 × 10⁹/L) caused by portal hypertension.
2. Include patients with a history of upper gastrointestinal hemorrhage and poor response to conservative treatment.
3. Include patients with liver function of Child-Pugh grade A or B⁶.

2. Exclusion criteria

1. Exclude patients with liver function of Child-Pugh grade C⁶, or with hepatic encephalopathy, severe jaundice, severe coagulation dysfunction, and massive ascites.
2. Exclude patients with extensive thrombus of the main portal vein, splenic vein, and superior mesenteric vein.
3. Exclude patients with heart, lung, kidney, and other vital organ dysfunction.
4. Exclude patients who could not tolerate general anesthesia or pneumoperitoneum.

3. Preoperative preparation

1. Perform preoperative blood tests, including liver and renal function tests, a complete blood count, coagulation function test, blood grouping, and crossmatching.
2. Perform electrocardiogram, chest X-ray, cardiovascular and hepatobiliary color Doppler ultrasound, and computed tomography (CT) of the upper abdomen before surgery.

4. Surgical technique

1. Position of the patient and surgeons
   1. Following tracheal intubation and general anesthesia (conducted according to institutionally approved protocols), position the patient supine with their legs spread 45° to 60°. Perform routine disinfection using povidone-iodine solution.
   2. Ensure that the surgeon is positioned on the right side of the patient, the assistant is on the left side, and the endoscope holder is placed between the patient's legs. The position of the surgeons can be adjusted according to personal habits.
2. Pneumoperitoneum establishment and trocar arrangement
   1. Make a longitudinal incision of 10 mm below the umbilicus, inject carbon dioxide gas through a pneumoperitoneum needle, and maintain an abdominal pressure of 12 mmHg (Figure 1).
   2. Insert a 10 mm trocar and the laparoscope below the umbilicus. Under the direct visualization provided by the laparoscope, place a 12 mm trocar in the left and right middle abdomen, respectively. Subsequently, position a 5 mm trocar in the left and right upper abdomen, respectively (Figure 1).
3. Splenic artery ligation
   1. Incise the gastrocolic and gastrosplenic ligaments using an ultrasonic-harmonic scalpel (Figure 2A,B). Ligate and sever the left gastroepiploic and short gastric vessels to expose the lesser omental sac and pancreas (Figure 2C).
   2. Incise the posterior peritoneum at the superior margin of the pancreas. Dissect and ligate the splenic artery (Figure 2D).
      NOTE: After splenic artery ligation, the surface color of the spleen becomes ischemic change, which is helpful in reducing the bleeding during splenectomy.
4. Splenectomy
   1. Starting from the lower pole of the spleen, sever the splenocolic ligament (Figure 3A). Lift the lower pole of the spleen ventrally and sever the splenorenal ligament (Figure 3B).
   2. Close to the splenic pedicle, separate the tail of the pancreas from the splenic pedicle. Close to the upper pole of the spleen, sever the splenophrenic ligament (Figure 3C).
      NOTE: At this point, the spleen is completely free.
   3. Sever the splenic pedicle using a linear stapling device with a cartridge (height 2.6 mm, length 60 mm) (Figure 3D).
      NOTE: When severing the splenic pedicle, pay attention to avoid damage to the pancreatic tail and prevent pancreatic leakage after surgery.
5. Pericardial devascularization
   NOTE: Devascularization for the left gastroepiploic and short gastric vessels have been done in the previous steps (Figure 2A,B).
   1. Lift and pull the stomach toward the cephalic side. Dissect and expose the left gastric vessels in the back of the stomach. Ligate and sever the left gastric vessels (Figure 4A).
   2. Dissociate the posterior wall of the stomach toward the cardia. Ligate and sever the posterior gastric vessels (Figure 4B).
   3. Pull the stomach toward the lower left. Incise the lesser omentum and anterior serosa of the cardia.
   4. Dissect and expose the branches of the gastric coronary vein entering the gastric wall. Ligate and sever the gastric branches of the coronary vein (Figure 4C).
   5. Incise the subphrenic anterior esophageal serosa. Dissect and dissociate the lower esophagus with a length not less than 6 cm. Ligate and sever the inferior phrenic vessels and the esophageal branches of the coronary vein (Figure 4D,E).
      NOTE: Pay attention to the possible presence of abnormally upper esophageal branches of the coronary vein; if present, ligation and incision are required (Figure 4F).
6. Specimen removal and surgery completion
   1. Carefully check for remaining varicose vessels around the cardia (Figure 5A). Load the resected spleen into a specimen bag (Figure 5B).
   2. Flush the surgical field using sterile saline (Figure 5C). Carefully examine for active bleeding, pancreatic and gastrointestinal collateral injury. Place a drainage tube under the left diaphragm (Figure 5D).
   3. Remove the trocars and extend the umbilical incision to approximately 3 cm in length. Crush the spleen within the specimen bag and remove it. Complete the surgery by suturing the abdominal wall incisions.

5. Postoperative procedures

1. Continuously monitor heart rate, blood pressure, respiratory rate, and temperature.
2. Administer intravenous antibiotics, somatostatin, and hepatoprotective drugs after the surgery.
3. Regularly check the incision site for signs of infection, such as redness, swelling, or discharge.
4. If no pancreatic leakage occurs, remove the abdominal drainage tube in 5-7 days after surgery.
5. Check the platelet count regularly. Anticoagulation or antiplatelet therapy is prescribed if the platelet count is too high or if venous thrombosis is present.

結果

A total of 8 patients (mean age: 50.75 years ± 6.43 years), including 6 males (75.0%) and 2 females (25.0%), were included. The cause of portal hypertension in all eight patients with cirrhosis was viral hepatitis. There were 5 patients (62.5%) with liver function classified as Child-Pugh grade A and 3 patients (37.5%) with Child-Pugh grade B. The mean major axis of the spleen for the patients was 196.50 mm ± 12.39 mm. The mean counts of white blood cells, hemoglobin, and platelets were (3.33 ± 0.81) ×...

ディスカッション

A large proportion of people in China suffer from chronic hepatitis, which is an important factor leading to liver cirrhosis^1,2. Patients with advanced liver cirrhosis often experience portal hypertension, resulting in a series of complications, such as splenomegaly, hypersplenism, peritoneal effusion, portal-systemic collateral circulation, and portal hypertensive gastroenteropathy^3,4,

資料

Name	Company	Catalog Number	Comments
10-mm trocar	Xiamen Surgaid Medical Device Co., LTD	NGCS 100-1-10	Sterile, ethylene oxide sterilized, disposable
12-mm trocar	Xiamen Surgaid Medical Device Co., LTD	NGCS 100-1-12	Sterile, ethylene oxide sterilized, disposable
5-mm trocar	Xiamen Surgaid Medical Device Co., LTD	NGCS 100-1-5	Sterile, ethylene oxide sterilized, disposable
Hem-o-lok	America Teleflex Medical Technology Co., LTD	544240	Sterile, ethylene oxide sterilized, disposable
Linear stapling device	America Ethicon Medical Technology Co., LTD	PSEE60A	Sterile, ethylene oxide sterilized, disposable
Pneumoperitoneum needle	Xiamen Surgaid Medical Device Co., LTD	NGCS 100-1	Sterile, ethylene oxide sterilized, disposable
Suction and irrigation tube	Tonglu Hengfeng Medical Device Co., LTD	HF6518.035	Sterile,dry heat sterilized, reusable
Ultrasounic-harmonic scalpel	Chongqing Maikewei Medical Technology Co., LTD	QUHS36S	Sterile, ethylene oxide sterilized, disposable